{
    "code": "02023128",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023128",
    "time": "2022-04-01 03:11:47",
    "許可證字號": "衛署藥輸字第023128號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/02\/20",
    "發證\/登錄日期": "90\/02\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202312807",
    "中文品名": "博脈舒　錠８公絲",
    "英文品名": "BLOPRESS TABLETS 8MG",
    "適應症": "1.本態性高血壓。\r\n2.治療左心室射出率≦40%之心臟衰竭病患，作為血管加壓素轉化酶抑制劑(ACE-inhibitors)輔助療法，或使用於無法耐受血管加壓素轉化酶抑制劑(ACE-inhibitors)的病人，以減少心臟血管死亡率或心衰竭導致之住院。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠瓶裝 Polypropylene (PP) 300 μm ALU foil盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CANDESARTAN CILEXETIL",
    "限制項目": "02輸　入",
    "申請商名稱": "620118P360  台灣賽特瑞恩有限公司",
    "申請商地址": "臺北市信義區松仁路97號3樓之1",
    "主製造廠": [
        {
            "": "ITALY",
            "製程": "製造、分裝"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005710",
            "成分名稱": "CANDESARTAN CILEXETIL",
            "含量描述": "",
            "含量": "8.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淺粉紅色",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "圓扁形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "TW_Blopress_8mg_ALU_r1_0610_6200528-01_tech approved (1)-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=002&Type=10"
        },
        {
            "title": "Blopress 8mg 外觀-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "TW_Blopress_8mg_LFT_r0-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=026&Type=9"
        },
        {
            "title": "TW_Blopress_8mg_LFT_r0-110-11-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=025&Type=9"
        },
        {
            "title": "PI_Blopress 8mg_ (Delpharm)-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=024&Type=9"
        },
        {
            "title": "PDF_A_for_Box_Blopress_8mg_91239230.rev1_20210617-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=006&Type=8"
        },
        {
            "title": "Blopress 8mg 外盒-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=005&Type=8"
        },
        {
            "title": "artwork_NEW_Blopress 8 mg Blister 7 tabl46.7x98mm_3. print-107-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=004&Type=8"
        },
        {
            "title": "artwork_NEW_Blopress 8mg Carton 28T TW 180130_Ap-107-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023128&Seq=003&Type=8"
        }
    ]
}